Physician

Hugo Francisco Fernandez, MD

According to 2025 Medicare claims, Hugo Fernandez, MD (NPI: 1437181674) practices hematology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SOUTH BROWARD HOSPITAL DISTRICT (NPI: 1780691865; TIN: 596014973) and primary practice location at 33026-4119. Fernandez is affiliated with the Broward Guardian, LLC (ACO ID: A2286), participating under the MSSP model.

Fernandez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 99 traditional Medicare patients, billed 319 HCPCS/CPT codes, and received $21,536 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 859 prescription claims across 106 beneficiaries totaling $3,754,953 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 67 claims. Open Payments data shows 9 records totaling $2,416. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $72,478 to $3,754,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	150	464	$35,300
2016	159	519	$39,234
2017	158	445	$33,690
2018	133	709	$61,109
2019	158	744	$67,465
2020	149	796	$68,948
2021	116	493	$41,327
2022	121	554	$44,889
2023	101	399	$28,598
2024	99	319	$21,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	66	586	$72,478
2016	74	750	$173,541
2017	86	795	$356,076
2018	90	905	$2,032,634
2019	114	817	$3,889,817
2020	126	1,024	$3,913,727
2021	111	1,022	$2,605,042
2022	124	1,061	$3,446,618
2023	114	947	$3,905,222
2024	106	859	$3,754,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	76	$30,788
2016	N/R	112	$25,946
2017	22	130	$18,176
2018	N/R	71	$12,611
2019	N/R	77	$11,002
2020	12	138	$28,834
2021	26	158	$310,277
2022	25	91	$5,560
2023	22	133	$5,981
2024	N/R	67	$2,068

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	22	33	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	57	77	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	12	37	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	68	123	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	63	1,890	$1,166,447
Revlimid	Lenalidomide	59	1,652	$889,006
Rezurock	Belumosudil Mesylate	22	900	$584,276
Calquence	Acalabrutinib Maleate	12	360	$172,670
Tasigna	Nilotinib Hcl	13	364	$101,009

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	35	$1,522
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	32	$546

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$416	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$2,000	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hugo Francisco Fernandez, MD?

Tedicare shows public-source Medicare data for Hugo Francisco Fernandez, MD (NPI 1437181674), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hugo Francisco Fernandez, MD have ACO affiliation data?

Hugo Francisco Fernandez, MD is shown with ACO affiliation data for Broward Guardian, LLC (MSSP, ACO ID A2286).

What billing organization is linked to Hugo Francisco Fernandez, MD?

Hugo Francisco Fernandez, MD is linked to SOUTH BROWARD HOSPITAL DISTRICT (billing NPI 1780691865) in the available physician profile data.

Does Hugo Francisco Fernandez, MD have Open Payments data?

Hugo Francisco Fernandez, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.